Cargando…
Cessation of antithrombotic therapy before surgery: weighing thrombosis and bleeding risks
Autores principales: | Meesters, M. I., Boer, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160462/ https://www.ncbi.nlm.nih.gov/pubmed/25055989 http://dx.doi.org/10.1007/s12471-014-0580-6 |
Ejemplares similares
-
Reversal of Antithrombotic Therapy: Is it Necessary and Sufficient?
por: Becker, Richard C.
Publicado: (2017) -
COVID-19: ACT trials for colchicine and antithrombotic therapies
por: Barco, Stefano, et al.
Publicado: (2022) -
COVID-19 as a barrier to attending for gastrointestinal endoscopy: weighing up the risks
por: Rees, Colin J, et al.
Publicado: (2020) -
Management of Antithrombotics before Endoscopy-Balancing the Risks
por: Kim, Joon Sung, et al.
Publicado: (2022) -
Effect of Antithrombotic Therapy on Secondary Bleeding After Proctological Surgery
por: Maemoto, Ryo, et al.
Publicado: (2021)